John Kaiser
2017 - Avalo Therapeutics
In 2017, John Kaiser earned a total compensation of $355.6K as Former Chief Business Officer and interim Chief Executive Officer at Avalo Therapeutics, a 21% decrease compared to previous year.
Compensation breakdown
| Option Awards | $27,055 |
|---|---|
| Salary | $321,871 |
| Other | $6,718 |
| Total | $355,644 |
Kaiser received $321.9K in salary, accounting for 91% of the total pay in 2017.
Kaiser also received $27.1K in option awards and $6.7K in other compensation.
Rankings
In 2017, John Kaiser's compensation ranked 12,910th out of 14,666 executives tracked by ExecPay. In other words, Kaiser earned more than 12.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,910 out of 14,666 | 12th |
Division Manufacturing | 5,086 out of 5,772 | 12th |
Major group Chemicals And Allied Products | 1,855 out of 2,075 | 11th |
Industry group Drugs | 1,545 out of 1,731 | 11th |
Industry Pharmaceutical Preparations | 1,196 out of 1,333 | 10th |
Source: SEC filing on April 5, 2018.
Kaiser's colleagues
We found five more compensation records of executives who worked with John Kaiser at Avalo Therapeutics in 2017.
2017
Uli Hacksell
Avalo Therapeutics
Chief Executive Officer
2017
Ronald Marcus
Avalo Therapeutics
Chief Medical Officer
2017
Mariam Morris
Avalo Therapeutics
Chief Financial Officer
2017
Peter Greenleaf
Avalo Therapeutics
Chief Executive Officer
2017
Robert Moscato
Avalo Therapeutics